Overview:

To estimate the current size of the global market for active pharmaceutical ingredients, the study involved four main activities. In order to gather data on the market, its parent market, and its peer markets, a thorough secondary research was conducted. The next stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to estimate the overall market size. The market size of the various segments and subsegments was then estimated using data triangulation and market breakdown.

Factors That Could Affect Global Growth:

The global APIs market is expanding due to several factors, including the rising prevalence of chronic illnesses, the growing significance of generics, and the growing adoption of biopharmaceuticals.

However, it is anticipated that the growth of this market will be constrained in the upcoming years by the unfavorable drug price control policies in place in many different countries as well as the rising prevalence of counterfeit drugs.

Revenue Growth Projection in Near Future:

With a predicted revenue of $145.9 billion in 2022 and a projected growth rate of 8.2% from 2022 to 2027, the global market for active pharmaceutical ingredients is expected to reach $216.4 billion.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263

Global Industry Segmentation:

The market for active pharmaceutical ingredients, or APIs, is divided into two categories based on type: innovative APIs and generic APIs.

In 2021, the creative APIs category is anticipated to rule this market. The market is being driven by factors like the costlier innovative APIs are in comparison to their generic counterparts. However, due to the global gradual switch in prescriptions from branded to generic medications, the generic APIs segment is anticipated to grow at a higher CAGR during the forecast period.

The market for active pharmaceutical ingredients (APIs) is divided into synthetic and biotech categories based on the type of synthesis.

In 2021, synthetic APIs should command a higher market share. The market is being driven by factors like the growing number of new product approvals and the increasing emergence of new molecules in the market.

The APIs market is divided into various categories based on therapeutic applications:

Including communicable diseases, oncology, cardiovascular diseases, diabetes, pain management, respiratory diseases, and other therapeutic applications (nephrology, endocrinology, orthopedics, ophthalmology, gastrointestinal disorders, CNS and neurological disorders). The global APIs market is divided into the largest segment, which is communicable diseases. The rising prevalence of infectious diseases worldwide and the rise in antibiotic resistance are some of the factors propelling the market's expansion.

Geographical Growth Scenario:

The market for active pharmaceutical ingredients is divided into four regions based on geography:

North America, Europe, Asia Pacific, and the Rest of the World. North America led the market in 2021, with Europe following closely behind. Over the course of the forecast period, the Asia Pacific market is anticipated to grow at the highest CAGR. The region's APIs market is driven by factors like the rising incidence of chronic illnesses, rising disposable income, and government initiatives to promote the use of generics.

Request Sample Pages for more Detailed Information@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=263

Global Leading Companies:

The global APIs (Active Pharmaceutical Ingredient) market has several big players. The key players in the market are Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), AstraZeneca (UK), Cipla, Inc. (India), Mylan N.V. (US), Dr. Reddy’s Laboratories Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), API Pharma Tech (India), BDR Pharmaceuticals Internationals Pvt. Ltd. (India), Sreepathi Pharmaceuticals Limited (India), Shilpa Medicare Limited (India), Evonik Industries AG (Germany), and Aurobindo Pharma Limited (India).

Growth Strategies Adopted by Them:

These players have furthered their global market presence through a variety of growth strategies, including agreements, partnerships, product launches, acquisitions, and collaborations.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]